When using ivermectin plus hydroxychloroquine for cancer, is it advisable to do a second round of administration for extra thoroughness? If so, after what interval?

We think a one-month delay would be reasonable. The ideal would be to have a check-in with us concerning advisability of an additional round. This should be usable for a wide spectrum of types of malignancy. There might be extreme cases such as a super aggressive and rapid-growing malignancy, and instances where there are widespread metastases so the load of malignant cells is quite high, where having some extra chemical firepower could be advantageous.